Loading...








Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Note: Free to use

[GMAB] Genmab - Time Machine

Data updated 2024-Jan-12 (Friday)
 


Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab 

Note: Historical Detail for Genmab as of 2024-Jan-12 (11 months ago) Market Close includes Performance (day & prior periods), Technical Indicators and Benchmarks. Use Related Links to view other info such as historical Financials and News for [NASDAQ:GMAB] as available

Share       
Other Dates:  
Time machine widget shows Historical Detail for Genmab on other dates (from 2009-Jun-01)
Historical Summary: 2024-Jan-12 Friday
 Open $31.59   High $31.97 +1.20%
 Close $31.61   Low $31.58 -0.03%
Volume 959 Thousand 1.21x Volatility 1.23%
Change $-0.28 -0.88%
Streak ↓ 4 days -3.54%

 20d SMA $31.61 0.0%  50d SMA $31.36 +0.8%  100d SMA $33.10 -4.5%  200d SMA $36.26 -12.8%
 RSI 49  MACD 0.02  ADX 9.2  Stochastic Oscillator 52.8 68.0
 CCI 19.1  ATR 0.74  OBV 15.9 Million  Chaikin A/D 20.4 Million
 
Health Care Biotechnology ADR:Denmark
Alerts: 50-day SMA 200-day Volume

Anomalies  AI

Anomaly Detection for Genmab looks at key performance metrics relative to it's history (upto 10 years) for Genmab to identify unusual levels for 2024-Jan-12:

  • Avg. 5-d Up performance at +3.7% is unusually high. Subsequent performance over next 200 days in such cases averages +31.3% and is up 79% of the time
  • 10-d Consistency at 30% is extremely low. Subsequent performance over next 100 days in such cases averages +15.3% and is up 74% of the time
  • 5-d Consistency at 20% is extremely low. Subsequent performance over next 100 days in such cases averages +16.2% and is up 74% of the time
  • Streak (days) at 4 down days is extremely low. Subsequent performance over next 50 days in such cases averages +7.0% and is up 73% of the time
    • ...
    Sign Up or Login to see more performance anomalies

    Anomaly Detection for Genmab looks at key technical metrics relative to it's history (upto 10 years) for Genmab to identify unusual levels for 2024-Jan-12:

  • ADX at 9.2 is extremely depressed. Subsequent performance over next 20 days in such cases averages +4.8% and is up 78% of the time. Subsequent performance over next 50 days in such cases averages +14.6% and is up 96% of the time
  • Chaikin A/D at 20 Million is unusually elevated. Subsequent performance over next 200 days in such cases averages +15.4% and is up 72% of the time
  • % off 200d SMA at -12.8% is extraordinarily depressed. Subsequent performance over next 200 days in such cases averages +25.0% and is up 72% of the time
    • ...
    Sign Up or Login to see more performance anomalies

     Anomaly Details
    Anomaly Detection uses Artificial Intelligence to find abnormal levels/metrics. Subsequent performance is aggregated for similar previous occurences in history and is called out if meaningful


    Choose view type

    Daily Performance for Genmab. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)



    Note: Performance over Key Timeperiods for Genmab up to close of 2024-Jan-12 at $31.61
    Period Frequency Performance % off High % off Low Volatility % off SMA % off EMA Relative Volume
    01 Trailing 5-days
    20% ↑80% ↓  
    0.00%  
    -3.9%  
    +1.3%  
    5.4%  
    -1.8%  
    -1.0%  
    1.21x  
    02 Trailing 10-days
    30% ↑70% ↓  
    -1.06%  
    -3.9%  
    +1.9%  
    6.0%  
    -1.0%  
    -0.9%  
    0.95x  
    03 Trailing 20-days
    45% ↑55% ↓  
    -0.69%  
    -3.9%  
    +3.4%  
    7.6%  
    0.0%  
    -0.5%  
    0.71x  
    04 Trailing 30-days
    50% ↑50% ↓  
    +1.06%  
    -3.9%  
    +6.0%  
    10.2%  
    -0.2%  
    -0.3%  
    0.81x  
    05 Trailing 50-days
    56% ↑44% ↓  
    +11.30%  
    -3.9%  
    +14.0%  
    18.6%  
    +0.8%  
    -0.8%  
    0.97x  
    06 Trailing 100-days
    49% ↑51% ↓  
    -13.75%  
    -20.0%  
    +14.0%  
    42.5%  
    -4.5%  
    -4.4%  
    1.22x  
    07 Trailing 200-days
    50% ↑51% ↓  
    -14.84%  
    -26.5%  
    +14.0%  
    55.0%  
    -12.8%  
    -9.3%  
    1.02x  
    08 Month-to-date
    33% ↑67% ↓  
    -0.72%  
    -3.9%  
    +1.9%  
    6.0%  
    09 Quarter-to-date
    33% ↑67% ↓  
    -0.72%  
    -3.9%  
    +1.9%  
    6.0%  
    10 Year-to-date
    33% ↑67% ↓  
    -0.72%  
    -3.9%  
    +1.9%  
    6.0%  
    11 Trailing 52-weeks
    48% ↑52% ↓  
    -20.98%  
    -26.5%  
    +14.0%  
    55.0%  
    Performance Benchmarks from 2024-Jan-12 for Genmab:


    Related to Genmab

    Information for Genmab
      : Recent daily/monthly performance & benchmark comparison
      : Historical performance & related information using Time Machine Currently Viewing
      : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
      : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
      : Investigate unusual recent performance & technicals with historical context using AI
      : Seasonal performance by calendar months
      : Popular Technical indicator trends (RSI, MACD etc.)
      : Contextualizing recent performance & technical levels into historical decile buckets
      : Dollar Cost Average (DCA) over time in your portfolio
      : Key Simple & Exponential Moving Averages
      : Insights from closest historical matches to recent performance using Artificial Intelligence
      : Insights from similar historical charts to recent chart using Artificial Intelligence
      News Stories : News stories on 2024-Jan-12 on Google
      SEC Reports : Quarterly reports around 2024-Jan-12 on SEC Edgar

    Compare Genmab with other assets
      : Recent performance across covered assets
      : Prior & Subsequent performance across assets on a historical date
      : Technical indicator levels across covered assets
      : Seasonal performance by calendar months across covered assets
      : Performance Correlations with other assets
      : Volatility relative to the broad market
      : Visually compare/benchmark performance with other assets over time
      : Contrast with other assets over time in a side-by-side presentation
      : Health Care sector performance which includes Genmab
      : Biotechnology industry performance which includes Genmab
    Analyze Genmab in multiple dimensions using above resources. Other comparable assets include other stocks/etfs/crypto etc.










    Ask brAIn  Experimental
    •  Hi! Ask me something. Use names or tickers to identify stock / etf / crypto symbols (e.g. aapl for Apple Inc.) . Click on below for examples of queries, list of special shortcuts & more